Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
AOD-9604 $49.99 AOD-9604 is a growth hormone fragment studied for selective fat metabolism without affecting growth or insulin pathways
If you are located in
With the 50 mg vial reconstituted in 2 ml, the concentration is fixed, so your unit count maps directly to milligrams
For weight management, NICE has appraised several licensed medicines that are available through NHS pathways or regulated private clinics: Semaglutide (Wegovy) NICE Technology Appraisal TA875 recommends semaglutide as an option for managing overweight and obesity in adults with a BMI of 35 kg/m or more (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, when used within a specialist weight management service
A single peptide influencing VEGF, NO pathways, and growth hormone receptor expression simultaneously is unusual in the regenerative medicine space 9
Eight panel members voted in favor, while six members voted against it
